ABEONA THERAPEUTICS INC. Receivables, Net, Current
ABEONA THERAPEUTICS INC. (ABEO) had Receivables, Net, Current of $7.00 million as of 2020-09-30, per its 10-Q filed 2020-11-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:ReceivablesNetCurrent · last filed 2020-11-09
- 2020-09-30: Receivables, Net, Current $7.00M.
- 2019-09-30: Receivables, Net, Current $15.00K.
- 2019-06-30: Receivables, Net, Current $40.00K.
- 2019-03-31: Receivables, Net, Current $38.00K.
| Period end | Receivables, Net, Current |
|---|---|
| 2020-09-30 | $7.00M 10-Q · filed 2020-11-09 |
| 2019-09-30 | $15.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $40.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $38.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $81.00K 10-K · filed 2020-03-16 |
| 2018-09-30 | $352.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $47.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $64.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $107.00K 10-K · filed 2019-03-18 |
| 2017-09-30 | $111.00K 10-Q · filed 2017-11-14 |
| 2017-06-30 | $97.00K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $148.00K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $124.00K 10-K · filed 2018-03-16 |
| 2016-09-30 | $606.00K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $112.00K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $244.00K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $115.00K 10-K · filed 2017-03-30 |
| 2015-09-30 | $271.00K 10-Q · filed 2015-11-16 |
| 2015-06-30 | $330.00K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $144.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $35.00K 10-K · filed 2016-03-30 |
| 2014-09-30 | $3.00K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $58.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $59.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $74.00K 10-K · filed 2015-03-31 |
| 2013-09-30 | $56.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $259.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $1.23M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $840.00K 10-K · filed 2014-03-26 |
| 2012-09-30 | $481.00K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $788.00K 10-Q · filed 2012-08-14 |
| 2012-03-31 | $934.00K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $333.00K 10-K · filed 2013-03-20 |
| 2011-09-30 | $119.00K 10-Q · filed 2011-11-14 |
| 2011-06-30 | $51.00K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $1.02M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |